SV Health to exit by February 2024
Ailsa Craig and Marek Poszepczynski to take over
Potential implications of US elections on investors
Vital signs to the past?
Outlooks for the biotech sector
Passive equity products have become popular over the past decade as it has become easier and cheaper to track the performance of an index.